XML 46 R13.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Licensing Agreements | 9 Months Ended
--- | ---
Jan. 31, 2014
Licensing Agreements [Abstract] |
Licensing Agreements Disclosure [Text Block] | Note 7. Licensing Agreements In February 2010, the Company entered into an exclusive option agreement with a Canadian company. The option agreement granted the Company the exclusive right to review Irinophore C, a nanoparticle drug compound, for the treatment of various forms of cancer, including melanoma, prostate, breast, and lung cancer through April 2011. During the option year, the Company performed various TumorGraft tests on the nanoparticle compound. In March 2011, the Company exercised its option to license Irinophore C, a liposomal formulation of Irinotecan. On the first anniversary of the agreement (March 2012), an additional license fee of $45,000 (Canadian) became due, which was recognized as a liability as of April 30, 2012 and was satisfied during the year ended April 30, 2013. Commencing with the second anniversary of the agreement (March 2013), the Company is obligated to pay a minimum annual royalty of $10,000 (Canadian), unless the agreement were terminated by either party in advance of the anniversary date. Under the terms of the license agreement, the Company will be required to pay up to $3.0 million in development milestones, if achieved. The Company does not believe development milestones will be achieved within the next 12 months. Upon commercialization, the Company would also be required to make royalty and sales milestone payments based upon revenues. As of April 30, 2013 the Company has paid the March 2013 annual royalty payment of $10,000 (Canadian). No accrual has been made for current year royalty payment due in March 2014.

X
- Details
Name: | csbr_LicensingAgreementsAbstract
Namespace Prefix: | csbr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure related to several different licensing agreements. + References No definition available. + Details
Name: | csbr_LicensingAgreementsDisclosureTextBlock
Namespace Prefix: | csbr_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration